Medicover, a leading international healthcare and diagnostic services company, announces the acquisition of InterGenetics Center for Medical Genetics and Genomics in Greece, thus strengthening its position in the genetic testing segment and regional reach. InterGenetics is a longstanding and respected provider of genetic services in Greece, founded to offer first-class medical genetic services, through a dynamic and close cooperation between the clinician and the geneticist.
The strategic acquisition of InterGenetics allows Medicover to expand its footprint into a new, geographically important growing market. With Medicover’s experience in both Laboratory and Clinical Genetics and advanced high-quality genetic services and reliable laboratory solutions, InterGenetics will provide an expanded portfolio to healthcare providers and patients.
>>> Read the announcement in Greek Language <<<
Dr. Stefan Mehrle, Head of Medicover Genetics International, stated: “The acquisition of InterGenetics into our portfolio within Medicover Genetics has a high strategic fit to our core strategy to combine medical expertise in clinical genetics with state-of-the-art genetic diagnostics. InterGenetics has a strong, long-lasting expertise in a highly attractive market in Greece, and we aim to leverage this potential by adding cutting edge technologies and a high level of diagnostic competency directly into the site in Greece, while at the same time building on and expanding the clinical genetics department to better serve patients and partners alike.”
Prof. Constantinos Pangalos, Scientific Director of InterGenetics, stated: “This is an exciting new era for InterGenetics. By joining our expertise in genetic medicine with Medicover we will chart a lasting future for the company, continuing to strengthen our position in Greece and abroad as a reliable and pioneering reference centre in the field.”
Earlier this year, Medicover announced the closing of its acquisition of NIPD Genetics, a leading innovative biotechnology company based in Cyprus, active in the design and development of comprehensive genetic solutions.